Healthcare Sales & Marketing Network News: molecular diagnostic

Searching News Database: molecular diagnostic

Your search returned too many results! The most recent 500 items are shown below:

HSMN NewsFeed - 1 Aug 2023
BD Receives 510(k) Clearance for COVID-19, Influenza A/B, RSV Molecular Combination Test
Diagnostics FDA

HSMN NewsFeed - 23 May 2023
Cepheid Announces Vitor Rocha as President
Diagnostics Personnel

HSMN NewsFeed - 28 Mar 2023
DCISionRT(R) by PreludeDx(TM) Receives Advanced Diagnostic Laboratory Test (ADLT) Status Approval from the Centers for Medicare & Medicaid Services
Diagnostics Oncology

HSMN NewsFeed - 28 Nov 2022
IDEAYA Biosciences Appoints Darrin M. Beaupre, M.D., Ph.D., as Chief Medical Officer to Lead Clinical Development of Expanding Clinical Pipeline
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 26 Sep 2022
BD, CerTest Biotec Announce US Commercial Launch of Monkeypox Assay
Diagnostics Product Launch

HSMN NewsFeed - 11 Jul 2022
DiamiR Biosciences Appoints Alidad Mireskandari, Ph.D., MBA, as Chief Executive Officer
Diagnostics Personnel

HSMN NewsFeed - 30 Jun 2022
BD Launches Combination Test for COVID-19, Influenza A/B and Respiratory Syncytial Virus
Diagnostics Product Launch

HSMN NewsFeed - 25 May 2022
Alercell Starts to Distribute Human Papilloma Virus (HPV) DNA Test
Diagnostics Product Launch

HSMN NewsFeed - 12 May 2022
BD Launches Fully Automated, High-Throughput Infectious Disease Molecular Diagnostic Platform in the U.S.
Diagnostics FDA Product Launch

HSMN NewsFeed - 7 Apr 2022
Sherlock Biosciences Appoints Karen Davies as Chief Development Officer
Diagnostics Personnel

HSMN NewsFeed - 14 Mar 2022
IDEAYA and Pfizer Expand Clinical Trial Collaboration and Supply Agreements for Evaluation of Darovasertib and Crizotinib Combination in Metastatic Uveal Melanoma and Additional cMET-Driven Tumors
Biopharmaceuticals Oncology

HSMN NewsFeed - 1 Feb 2022
Biofidelity Raises $23M in Series A+ Financing led by Octopus Ventures to Launch ASPYRE Technology
Diagnostics Oncology Venture Capital

HSMN NewsFeed - 17 Dec 2021
BD Expands Fully Automated High-Throughput Molecular Diagnostic Platform for Core Labs
Diagnostics Regulatory

HSMN NewsFeed - 22 Oct 2021
BD Names Dr. Carrie Byington To Board Of Directors
Devices Personnel

HSMN NewsFeed - 25 Aug 2021
BD Launches Fully Automated High-Throughput Molecular Diagnostic Platform for U.S. Laboratories
Diagnostics Product Launch

HSMN NewsFeed - 23 Aug 2021
Elixiron Immunotherapeutics Announces Closing of $27 Million Series A-1 Financing Round to Progress Alzheimer's Disease and Vitiligo Clinical-Stage Assets
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 10 Mar 2021
Luminex Submits Joint SARS-CoV-2 and Flu/RSV Respiratory Panel to FDA for Emergency Use Authorization
Diagnostics FDA

HSMN NewsFeed - 23 Feb 2021
Co-Diagnostics, Inc. Announces New Chief Financial Officer
Diagnostics Personnel

HSMN NewsFeed - 17 Feb 2021
IDEAYA Biosciences Appoints Susan L. Kelley, M.D., an Industry Veteran in Medical Oncology and Clinical Development, to its Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 12 Feb 2021
BD Announces Emergency Use Authorization, CE Mark for Combination Molecular Diagnostic to Detect SARS-CoV-2, Influenza A+B in Single Test
Diagnostics FDA Regulatory

HSMN NewsFeed - 14 Jan 2021
SML Genetree Receives FDA Emergency Use Authorization for Ezplex SARS-CoV-2 G Real-Time PCR Kit with Specimen Pooling Capability
Diagnostics FDA

HSMN NewsFeed - 9 Dec 2020
Mesa Biotech Receives 510(k) Clearance and CLIA Waiver for Its Accula(TM) Strep A Molecular Point of Care Test
Diagnostics FDA

HSMN NewsFeed - 5 Nov 2020
Micronoma Expands Executive Team and Operations
Diagnostics Oncology Personnel

HSMN NewsFeed - 22 Jul 2020
BD receives FDA Approval for HPV Test with Extended Genotyping Capabilities
Diagnostics Oncology FDA

HSMN NewsFeed - 6 Jul 2020
BD Launches Portable, Rapid Point-of-Care Antigen Test to Detect SARS-CoV-2 in 15 minutes, Dramatically Expanding Access to COVID-19 Testing
Diagnostics FDA Product Launch

HSMN NewsFeed - 10 Jun 2020
FDA Issues Emergency Use Authorization for ChromaCode's High-Throughput HDPCR(TM) SARS-CoV-2 Real-Time PCR Assay
Diagnostics FDA

HSMN NewsFeed - 19 May 2020
ChromaCode Raises $10 Million Series C Financing From Adjuvant Capital
Diagnostics Venture Capital

HSMN NewsFeed - 19 May 2020
ArcherDX Receives Breakthrough Device Designation to Detect NTRK Gene Fusions
Diagnostics Oncology FDA

HSMN NewsFeed - 7 May 2020
OPTI Medical Systems Receives US FDA Emergency Use Authorization for Its OPTI SARS-CoV-2 RNA PCR Test Kit for Detection of the Virus Causing COVID-19
Diagnostics FDA

HSMN NewsFeed - 4 May 2020
SutroVax Appoints Andrew Guggenhime as Chief Financial Officer and Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 May 2020
Co-Diagnostics, Inc. Announces Government Approvals and Increased Orders for COVID-19 Test Kits
Diagnostics Regulatory

HSMN NewsFeed - 1 May 2020
Co-Diagnostics, Inc. Releases COVID-19 Test Performance Data: Consistently Demonstrates 100% Sensitivity and 100% Specificity Across Independent Evaluations
Diagnostics

HSMN NewsFeed - 21 Apr 2020
IDEAYA Biosciences Announces Addition of Julie Patel as Vice President, Human Resources, Enhancing its Leadership Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Apr 2020
Biocept Launches Unique Line of Molecular Assay Kits for Detection of Key Oncogene Mutations Based on its Proprietary Target Selector(TM) Technology Validated for Use in Both Tissue and Blood Samples
Diagnostics Oncology Product Launch

HSMN NewsFeed - 15 Apr 2020
Mesa Biotech Announces Ingo Chakravarty as President and CEO
Diagnostics Personnel

HSMN NewsFeed - 6 Apr 2020
Luminex Receives FDA Emergency Use Authorization for ARIES(R) SARS-CoV-2 Assay to Detect Virus Responsible for COVID-19 Disease
Diagnostics FDA

HSMN NewsFeed - 6 Apr 2020
Co-Diagnostics, Inc Receives FDA Emergency Use Authorization for COVID-19 Test
Diagnostics FDA Product Launch

HSMN NewsFeed - 3 Apr 2020
BD, BioGX Announce FDA Emergency Use Authorization for New COVID-19 Diagnostic for Use in U.S.
Diagnostics FDA

HSMN NewsFeed - 26 Mar 2020
Immunexpress Receives CE Mark and Signs European Commercialization Partnership for SeptiCyte(R) RAPID
Diagnostics Regulatory

HSMN NewsFeed - 6 Mar 2020
PreludeDx Announces New Response Type Biosignature Data at the 37th Annual Miami Breast Cancer Conference
Diagnostics Oncology

HSMN NewsFeed - 17 Feb 2020
PharmaMar and Jazz Pharmaceuticals Announce FDA Acceptance and Priority Review of New Drug Application for Lurbinectedin in Relapsed Small Cell Lung Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 14 Feb 2020
Biocept Appoints Cory J. Dunn Senior Vice President of Commercial Operations
Diagnostics Oncology Personnel

HSMN NewsFeed - 22 Jan 2020
PharmaMar and Jazz Pharmaceuticals Announce the U.S. License Agreement for Lurbinectedin is Effective with the Expiration of the HSR Waiting Period
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 10 Jan 2020
Inflammatix Announces $32 Million in Series C Funding
Diagnostics Venture Capital

HSMN NewsFeed - 3 Jan 2020
Breast Cancer Patients in Germany Now have Insurance Coverage for MammaPrint(R) Testing through Techniker Krankenkasse
Diagnostics Oncology Reimbursement

HSMN NewsFeed - 17 Dec 2019
ArcherDX Announces Close of $55 Million Series C Financing
Diagnostics Venture Capital

HSMN NewsFeed - 17 Dec 2019
ChromaCode Raises $28 Million in Series C Financing
Diagnostics Venture Capital Personnel

HSMN NewsFeed - 5 Dec 2019
Black Diamond Therapeutics Closes $85 Million Series C Financing
Biopharmaceuticals Oncology Venture Capital Personnel

HSMN NewsFeed - 21 Nov 2019
Biocept Announces the Launch of its Liquid Biopsy Test to Detect TRK Biomarkers in the Blood of Patients Diagnosed with Cancer
Diagnostics Oncology Product Launch

HSMN NewsFeed - 7 Nov 2019
Biocept Announces CE IVD Marks and Availability of its CEE-Sure(R) Blood Collection Tube and Sample Collection Shipping Kit in Europe
Diagnostics Oncology Regulatory Product Launch

HSMN NewsFeed - 30 Oct 2019
Third Pole Therapeutics Names Bill Athenson New CEO
Devices Drug Delivery Personnel

HSMN NewsFeed - 22 Oct 2019
BioGX Receives CE-IVD Mark For Enhanced Flu Assay
Diagnostics Regulatory

HSMN NewsFeed - 14 Oct 2019
Exact Sciences And Mayo Clinic Initiate 150,000 Patient, 7-Year Study To Evaluate Real-World Impact Of Cologuard(R)
Diagnostics Oncology Gastroenterology

HSMN NewsFeed - 11 Oct 2019
Transplant Genomics, Inc. Confirms TruGraf(R) Will Receive Medicare Coverage Effective November 25, 2019
Diagnostics Reimbursement

HSMN NewsFeed - 23 Sep 2019
Cologuard(R) Gains FDA Approval For Use In Younger Americans, Ages 45 To 49
Diagnostics Oncology FDA

HSMN NewsFeed - 18 Sep 2019
Study Demonstrates Value of ChromaCode HDPCR(TM) Testing for Tick-Borne Pathogens
Diagnostics

HSMN NewsFeed - 11 Sep 2019
Immunexpress Appoints Jane Papadaki Markley as VP of Market Development and Commercial Operations
Diagnostics Personnel

HSMN NewsFeed - 10 Sep 2019
Cologuard(R) Helps More People Get Screened In A Cost-Effective Way
Diagnostics Oncology

HSMN NewsFeed - 29 Aug 2019
Richard Creager Joins Ubiquitome Board of Directors
Diagnostics Personnel

HSMN NewsFeed - 26 Aug 2019
Atonarp Inc. Announces $33 Million Series C Funding Round Completion
Diagnostics Venture Capital

HSMN NewsFeed - 24 Jul 2019
Pathnostics Announces CEO Appointment
Diagnostics Personnel

HSMN NewsFeed - 9 Jul 2019
IDEAYA Biosciences Strengthens Management with Internal Appointments of Paul Stone, J.D., as Chief Financial Officer, Andres Ruiz Briseno, C.P.A., as Vice President, Finance, and Mick O'Quigley, M.B.A, as Vice President, Development Operations
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 17 May 2019
Exact Sciences Presents New Data Reinforcing Performance of Cologuard(R)
Diagnostics Gastroenterology Oncology

HSMN NewsFeed - 16 May 2019
GenePOC Obtains FDA Clearance for its GenePOC(TM) Carba Test in the US
Diagnostics FDA

HSMN NewsFeed - 30 Apr 2019
510(k) Market Clearance for FluChip-8G Influenza A+B Assay
Diagnostics FDA

HSMN NewsFeed - 22 Apr 2019
Epic Sciences Appoints Richard J. Wenstrup, M.D. as Chief Medical Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 22 Mar 2019
Bruker Announces Improved Assay for Tuberculosis Diagnostics in Novel Liquid Array(TM) Format for Improved Multiplexing
Diagnostics Product Launch

HSMN NewsFeed - 19 Mar 2019
Abbott Announces CE Mark for Alinity(TM) m Diagnostics System and Assays, the Latest in Molecular Technology, to Help Deliver Critical Test Results and Benefits to Patients
Diagnostics Regulatory

HSMN NewsFeed - 27 Feb 2019
Cologuard Helps Screen Two Million People for Colorectal Cancer
Diagnostics Oncology

HSMN NewsFeed - 28 Jan 2019
Biocept Launches Liquid Biopsy Kits Intended to Broaden Use of its Proprietary Technology Platform for High Sensitivity Detection of Circulating Tumor DNA
Diagnostics Oncology Product Launch

HSMN NewsFeed - 3 Jan 2019
Clinical Genomics Appoints Betsy Hanna CEO
Diagnostics Oncology Personnel

HSMN NewsFeed - 20 Dec 2018
Cepheid Receives CE-IVD Clearance for Xpert� HBV Viral Load
Diagnostics Regulatory Product Launch

HSMN NewsFeed - 27 Nov 2018
Mesa Biotech Receives FDA 510(k) Clearance and CLIA Waiver for Its Accula(TM) RSV Molecular Point of Care Test
Diagnostics FDA

HSMN NewsFeed - 5 Nov 2018
Biocept Announces New Executive Hires to its Sales and Marketing Organization
Diagnostics Oncology Personnel

HSMN NewsFeed - 25 Oct 2018
Abbott Introduces the Next Generation of Influenza A & B and Strep A Assays with Fastest-Ever Time to Molecular Results
Diagnostics FDA Product Launch

HSMN NewsFeed - 23 Oct 2018
BioGX Launches 5 new CE Mark IVD Tests, Expands Sexual Health Panels on the BD MAX(TM)
Diagnostics Regulatory Product Launch

HSMN NewsFeed - 12 Oct 2018
FDA Approves Grifols ID CORE XT Test For Molecular Red Blood Cell Typing
Diagnostics FDA

HSMN NewsFeed - 10 Sep 2018
Biocept Names Edwin C. Hendrick as Senior Vice President, Chief Commercial Officer
Diagnostics Oncology Personnel

HSMN NewsFeed - 24 Aug 2018
Bruker Announces Agreement to Acquire Majority in Infectious Disease-focused Molecular Diagnostics (MDx) Company Hain Lifescience GmbH
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 23 Aug 2018
Roche receives FDA approval for cobas EGFR Mutation Test v2 as companion diagnostic with IRESSA (gefitinib) in first-line treatment of patients with non-small cell lung cancer (NSCLC)
Diagnostics Oncology FDA

HSMN NewsFeed - 22 Aug 2018
Exact Sciences and Pfizer Enter into U.S. Promotion Agreement for Cologuard(R)
Diagnostics Oncology

HSMN NewsFeed - 21 Aug 2018
Akonni Biosystems Awarded NIH Grant to Support the Advancement of its Point-of-Care Diagnostic Platform
Diagnostics

HSMN NewsFeed - 6 Aug 2018
CureGenetics raises $17 million in Series A Financing
Biopharmaceuticals Diagnostics Personnel

HSMN NewsFeed - 27 Jul 2018
PharmaMar Reaches an Agreement With Impilo Pharma, a Part of Immedica Group, for the Promotion and Distribution of Yondelis(R) in the Nordic Countries and Eastern Europe
Biopharmaceuticals Oncology Distribution

HSMN NewsFeed - 26 Jul 2018
Cepheid Receives FDA Clearance and CLIA Waiver for Xpert(R) Xpress Flu/RSV Test
Diagnostics FDA Product Launch

HSMN NewsFeed - 19 Jun 2018
GenomeDx Biosciences and Pathnostics Launch Enhanced Version of Guidance Tests
Diagnostics Oncology Product Launch

HSMN NewsFeed - 14 Jun 2018
New England Biolabs(R) Launches New NEBNext(R) Single Cell/Low Input RNA Library Prep Kit for Increased Transcript Detection with Ultra-low Input Amounts
Diagnostics Product Launch

HSMN NewsFeed - 13 Jun 2018
Akonni Biosystems Announces the Appointment of Lawrence Firestone as Executive Vice President and Chief Financial Officer
Diagnostics Personnel

HSMN NewsFeed - 24 May 2018
BioGX Launches Six CE-Mark Tests for Meningitis and Antibiotic Resistance
Diagnostics Product Launch

HSMN NewsFeed - 15 May 2018
FDA Clears Expanded Claims for 'Superbug' Test
Diagnostics FDA

HSMN NewsFeed - 14 May 2018
FDA approves additional claim for Roche cobas Zika test
Diagnostics FDA

HSMN NewsFeed - 10 May 2018
Interpace Diagnostics Announces Expanded Coverage Among Blue Cross Blue Shield Plans
Diagnostics Oncology Reimbursement

HSMN NewsFeed - 1 May 2018
Agendia's MammaPrint(R) Receives Positive Coverage Decisions from Three Major Private Healthcare Insurers
Diagnostics Personalized Medicine Oncology Reimbursement

HSMN NewsFeed - 16 Apr 2018
Roche receives FDA clearance for cobas(R) CT/NG for cobas(R) 6800/8800 Systems
Diagnostics FDA

HSMN NewsFeed - 11 Apr 2018
Sysmex Inostics: OncoBEAM(TM) RAS CRC Liquid Biopsy Test Now Reimbursed in Germany by BARMER
Diagnostics Oncology Reimbursement

HSMN NewsFeed - 30 Mar 2018
Epic Sciences and Genomic Health Announce Favorable Draft Local Coverage Determination (LCD) on Medicare Coverage for Use of the Oncotype DX(R) AR-V7 Nucleus Detect(TM) Test in Patients with Metastatic Castration-Resistant Prostate Cancer
Diagnostics Oncology Reimbursement

HSMN NewsFeed - 20 Mar 2018
Mark Stenhouse to join Exact Sciences as President, Cologuard
Diagnostics Oncology Personnel

HSMN NewsFeed - 19 Feb 2018
GenePOC Launches Its revogene(TM) Instrument and GBS LB Test in Canada
Diagnostics Product Launch

HSMN NewsFeed - 18 Jan 2018
Clinical Genomics appoints Tadd Lazarus, M.D., as Chief Medical Officer
Diagnostics Oncology Personnel

HSMN NewsFeed - 15 Jan 2018
BD and Check-Points Receive CE Mark for Next-generation Resistant Bacteria Screening Test
Diagnostics Regulatory

HSMN NewsFeed - 2 Jan 2018
Abbott Launches Alinity(TM) h-series Integrated Hematology System, Combining Speed, Accuracy and Seamless Integration
Devices Diagnostics Product Launch

HSMN NewsFeed - 19 Dec 2017
Agendia and Bluebee Partner to Bring New NGS-based MammaPrint(R) BluePrint(R) Breast Cancer Kit to Market
Diagnostics Personalized Medicine Oncology Product Launch

HSMN NewsFeed - 19 Dec 2017
Inflammatix Announces Appointment of Oliver Liesenfeld, M.D., as Chief Medical Officer
Diagnostics Personnel

HSMN NewsFeed - 14 Dec 2017
Medimetriks Pharmaceuticals, Inc. Receives FDA Approval for Xepi(TM) (ozenoxacin) Cream, 1%, a Novel Topical Antibiotic for Impetigo
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 28 Nov 2017
GenePOC Launches its GenePOC(TM) CDiff Test in the United States
Diagnostics FDA Product Launch

HSMN NewsFeed - 31 Oct 2017
Abbott Announces FDA Clearance for its Alinity(TM) ci-series Next-generation Diagnostic Systems
Diagnostics FDA

HSMN NewsFeed - 5 Oct 2017
Cepheid Expands Respiratory Disease Portfolio with Xpert Xpress Strep A
Diagnostics FDA

HSMN NewsFeed - 2 Oct 2017
Alere Receives FDA Clearance for Alere(TM) i Influenza A & B 2 Rapid Molecular Test
Diagnostics FDA

HSMN NewsFeed - 18 Sep 2017
Tetracore(R) Inc. Announces European Approval of the T-COR 8(TM) Portable Real-time PCR Thermocycler
Diagnostics Regulatory

HSMN NewsFeed - 15 Sep 2017
Myriad Genetics Announces Positive Data Supporting New riskScore(TM) Test at the 36th Annual Conference of the National Society of Genetic Counselors
Diagnostics Personalized Medicine Oncology

HSMN NewsFeed - 7 Sep 2017
Hereditary Cancer Risk Assessment Is an Important Option for Prostate Cancer Patients during Prostate Cancer Awareness Month
Diagnostics Oncology

HSMN NewsFeed - 5 Sep 2017
Biocept Launches Liquid Biopsy Test for NRAS Mutations
Diagnostics Oncology Product Launch

HSMN NewsFeed - 18 Aug 2017
EndoPredict(R) Receives Positive Coverage Decisions From Medicare and Anthem
Diagnostics Oncology Reimbursement

HSMN NewsFeed - 14 Aug 2017
Biocept Enters Into Exclusive Distribution Agreement with Global Laboratory Product Supplier VWR
Diagnostics Oncology Distribution

HSMN NewsFeed - 10 Aug 2017
Biocept Announces Private Placement of $2.2 Million of Common Stock with Ally Bridge LB Healthcare Master Fund
Diagnostics Oncology Venture Capital

HSMN NewsFeed - 24 Jul 2017
Luminex Corporation Receives FDA Clearance for ARIES C. difficile Assay
Diagnostics FDA

HSMN NewsFeed - 14 Jul 2017
Biocept Expands Commercial Offering of Clinically Actionable Biomarker Assays with Launch of Liquid Biopsy Test for Progesterone Receptor Detection
Diagnostics Oncology Product Launch

HSMN NewsFeed - 11 Jul 2017
Evelo Biosciences Announces $50 Million Series B Financing and Expansion of Board and Leadership Team
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 29 Jun 2017
HYCOR Biomedical Announces Senior Level Appointments to Management Team
Diagnostics Personnel

HSMN NewsFeed - 28 Jun 2017
Luminex Corporation Receives CE-IVD Mark for ARIES(R) Norovirus Assay
Diagnostics Regulatory

HSMN NewsFeed - 20 Jun 2017
Hologic Announces FDA Clearance of Aptima(R) Assay to Detect Herpes Simplex Virus 1 & 2
Diagnostics FDA

HSMN NewsFeed - 8 Jun 2017
QIAGEN's QuantiFERON(R)-TB Gold Plus gains U.S. FDA approval
Diagnostics FDA

HSMN NewsFeed - 5 Jun 2017
BD Receives FDA 510(K) Clearance for Molecular Test for Harmful Intestinal Bacteria Causing Infectious Diarrhea
Diagnostics FDA

HSMN NewsFeed - 1 Jun 2017
GenePOC Announces FDA Clearance for Revogene(TM) Instrument and its GBS LB Test
Diagnostics FDA

HSMN NewsFeed - 25 May 2017
Medicare Coverage of Prolaris(R) Test Expands with the Addition of Men Diagnosed with Favorable Intermediate Risk Prostate Cancer
Diagnostics Oncology Reimbursement

HSMN NewsFeed - 18 May 2017
Biotheranostics Appoints Don Hardison as New CEO
Diagnostics Personalized Medicine Personnel

HSMN NewsFeed - 3 May 2017
Luminex Corporation Receives FDA Clearance for ARIES Bordetella Assay
Diagnostics FDA

HSMN NewsFeed - 28 Apr 2017
Invivoscribe(R) Receives FDA Approval for the LeukoStrat(R) CDx FLT3 Mutation Assay Companion Diagnostic Test for the Selection of Patients for Rydapt(R) and is the First Companion Diagnostic for AML
Diagnostics Personalized Medicine Oncology FDA

HSMN NewsFeed - 28 Apr 2017
Novartis Receives FDA Approval for Rydapt(R) in Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia (AML) and Three Types of Systemic Mastocytosis (SM)
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 27 Apr 2017
Cologuard Growth Accelerates to $48.4 Million in Revenue During First Quarter; Volume Grows 150 Percent Year Over Year to 100,000 Completed Tests
Diagnostics Oncology

HSMN NewsFeed - 25 Apr 2017
AltheaDx Closes $27 Million Series D Financing
Diagnostics Personalized Medicine Venture Capital

HSMN NewsFeed - 12 Apr 2017
Cxbladder Monitor Significantly Outperforms All Compared FDA Approved Urine Tests For Bladder Cancer; Enhancing The Standard Of Care For Bladder Cancer Patients
Diagnostics Urology Oncology

HSMN NewsFeed - 13 Mar 2017
Myriad Genetics Launches the EndoPredict(R) Test in the United States for Patients with Breast Cancer
Diagnostics Oncology Product Launch

HSMN NewsFeed - 23 Feb 2017
First-Ever Device for Fast and Virtually Painless Blood Draw Receives FDA Clearance
Devices FDA

HSMN NewsFeed - 20 Feb 2017
DiaCarta Receives CE-IVD for its Non-Invasive Colorectal Cancer Test - ColoScape(TM) Real-Time PCR Kit
Diagnostics Oncology Regulatory

HSMN NewsFeed - 15 Feb 2017
Cepheid Announces FDA Clearance Of Xpert(R) Xpress Flu And Xpert Xpress Flu/RSV
Diagnostics FDA

HSMN NewsFeed - 26 Jan 2017
CrownBio Announces Expansion of Life Science Division
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Jan 2017
Akonni Biosystems Strengthens Leadership Team with Multiple Key Appointments
Diagnostics Personnel

HSMN NewsFeed - 7 Nov 2016
Myriad Will Seek Japanese Regulatory Approval for BRACAnalysis CDx(R)
Diagnostics Oncology Regulatory

HSMN NewsFeed - 4 Nov 2016
The GeneSight(R) Precision Medicine Test Drives Significant Medication Cost Savings in Patients with Generalized Anxiety Disorder
Diagnostics Personalized Medicine

HSMN NewsFeed - 1 Nov 2016
miRagen Therapeutics and Signal Genetics Sign Merger Agreement
Diagnostics Oncology Mergers & Acquisitions

HSMN NewsFeed - 31 Oct 2016
BD MAX(TM) Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Diagnostics FDA

HSMN NewsFeed - 27 Oct 2016
The Myriad myPath(R) Melanoma Test Effectively Diagnosed Patients in the Largest Outcomes-Based Study for a Melanoma Diagnostic
Diagnostics Dermatology Oncology

HSMN NewsFeed - 20 Oct 2016
Rosetta Genomics Appoints Mark R. Willig as Chief Commercial Officer
Diagnostics Oncology Personnel

HSMN NewsFeed - 19 Oct 2016
GeneFirst Announces CE Marking and Release of Papilloplex(R) HR-HPV, a PCR Based Molecular Diagnostic Test for Genotyping 14 High Risk Human Papillomaviruses from Cervical and Urine Samples
Diagnostics Regulatory Product Launch

HSMN NewsFeed - 6 Oct 2016
Interpace Diagnostics Launches New Streamlined Molecular Product for Pancreatic Cysts
Diagnostics Oncology Product Launch

HSMN NewsFeed - 29 Sep 2016
Myriad Appoints Chip Parkinson as EVP for Reimbursement Strategy
Diagnostics Personnel

HSMN NewsFeed - 6 Sep 2016
BD Submits Pre-Market Approval Application to FDA for BD Onclarity(TM) HPV Test
Diagnostics FDA

HSMN NewsFeed - 29 Aug 2016
Roche receives FDA Emergency Use Authorization for Zika PCR Test
Biopharmaceuticals FDA

HSMN NewsFeed - 1 Aug 2016
Roche receives CLIA waiver for cobas(R) Influenza A/B & RSV test for the cobas(R) Liat(R)
Diagnostics FDA

HSMN NewsFeed - 27 Jul 2016
Biocept Appoints Timothy C. Kennedy as Chief Financial Officer and Senior Vice President of Operations
Diagnostics Oncology Personnel

HSMN NewsFeed - 13 Jun 2016
Collegium Announces Election of John A. Fallon, M.D. to Board of Directors
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 3 Jun 2016
Exact Sciences Appoints Jeff Elliott to Lead Business Development & Strategy
Diagnostics Personnel

HSMN NewsFeed - 25 May 2016
Roche announces the first FDA-approved CMV test for use in hematopoietic stem cell transplant recipients
Diagnostics FDA

HSMN NewsFeed - 23 May 2016
Interpace Diagnostics Presents New Clinical Utility Data at Digestive Disease Week
Diagnostic Gastroenterology Oncology

HSMN NewsFeed - 17 May 2016
Mesa Biotech Announces Key Additions to Executive Management Team
Diagnostics Personnel

HSMN NewsFeed - 16 May 2016
Luminex Corporation Signs Definitive Agreement to Acquire Nanosphere, Inc.
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 9 May 2016
Personal Genome Diagnostics Names Industry Veteran Douglas Ward as Chief Executive Officer
Diagnostics Personalized Medicine Personnel

HSMN NewsFeed - 3 May 2016
Exact Sciences Completes 40,000 Cologuard Tests during First Quarter 2016
Diagnostics Oncology

HSMN NewsFeed - 21 Apr 2016
Abbott Introduces New Services and Tools to Help Labs Deliver Greater Operational Productivity
Diagnostics Product Launch

HSMN NewsFeed - 18 Apr 2016
Interpace Diagnostics Announces New Coding by Novitas Solutions for PancraGen(TM)
Diagnostics Oncology Reimbursement

HSMN NewsFeed - 6 Apr 2016
Merck and Sysmex Inostics Receive CE Mark Approval for Liquid Biopsy test for Colorectal Cancer Patients
Diagnostics Oncology Regulatory

HSMN NewsFeed - 6 Apr 2016
Sorrento Appoints Kevin M. Herde As Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Mar 2016
The Myriad myRisk(R) Hereditary Cancer Test Identifies 60 Percent More Deleterious Mutations in Patients with Endometrial Cancer
Diagnostics Oncology Personalized Medicine

HSMN NewsFeed - 10 Mar 2016
ProMark(R) Prostate Cancer Prognostic Now Included in NCCN Guidelines
Diagnostics Oncology

HSMN NewsFeed - 25 Feb 2016
Anthem BCBS Georgia and Virginia Contracted to Cover Cologuard as In-Network Service
Diagnostics Oncology Reimbursement

HSMN NewsFeed - 19 Feb 2016
Veracyte Announces Publication of Study Reinforcing the Clinical Utility of the Afirma(R) Gene Expression Classifier in Thyroid Cancer Diagnosis
Diagnostics Oncology

HSMN NewsFeed - 17 Feb 2016
Interpace Diagnostics Receives Medicare Coverage For Its ThyraMIR(TM) Micro RNA Gene Expression Classifer
Diagnostics Oncology Reimbursement

HSMN NewsFeed - 15 Feb 2016
Collaboration led by ImmunID Awarded Innovate UK Grant to Advance Program on Prediction of Response to Cancer Immunotherapy using ImmunTraCkeR(R)
Diagnostics Personalized Medicine Oncology

HSMN NewsFeed - 8 Feb 2016
Atlas Genetics Gains CE Approval for First Product
Diagnostics Regulatory

HSMN NewsFeed - 1 Feb 2016
Trovagene Enters into Agreement with FedMed, Inc. and Significantly Expands Patient Access to Its Precision Cancer Monitoring Platform
Diagnostics Oncology

HSMN NewsFeed - 25 Jan 2016
Exact Sciences Announces Appointment of John A. Fallon, M.D., to Company's Board of Directors
Diagnostics Oncology Personnel

HSMN NewsFeed - 22 Jan 2016
Veracyte Announces Publication of Long-Term Clinical Utility Study for the Afirma(R) Gene Expression Classifier
Diagnostics Oncology

HSMN NewsFeed - 20 Jan 2016
Interpace Diagnostics Announces New Medicare Local Coverage Determination for Molecular Testing of Pancreatic Cysts
Diagnostics Oncology Reimbursement

HSMN NewsFeed - 19 Jan 2016
HiberGene Closes First Tranche of Series B Financing
Diagnostics Venture Capital

HSMN NewsFeed - 13 Jan 2016
Epistem Appoints David Budd as Chief Executive Officer
Diagnostics Personalized Medicine Personnel

HSMN NewsFeed - 12 Jan 2016
Interpace Diagnostics' New Molecular Test for Thyroid Nodules Now Available Through LabCorp
Diagnostics Oncology

HSMN NewsFeed - 8 Jan 2016
MDNA Life Sciences Appoints New Management Team Members to Lead Development and Commercialization of Mitochondrial Diagnostic Pipeline
Diagnostics Oncology Personnel

HSMN NewsFeed - 8 Jan 2016
Counsyl Appoints Ted Snelgrove as Chief Business Officer
Diagnostics Personnel

HSMN NewsFeed - 7 Jan 2016
Exosome Diagnostics Completes $60 Million Series B Financing
Diagnostics Oncology Venture Capital

HSMN NewsFeed - 6 Jan 2016
Origin Sciences Secures North American Distributor
Devices Diagnostics Distribution

HSMN NewsFeed - 21 Dec 2015
Roche receives FDA approval for HIV-1 viral load test on the cobas(R) 6800/8800 Systems
Diagnostics HIV/AIDS FDA

HSMN NewsFeed - 23 Nov 2015
Akers Biosciences Appoints Medical Technology Specialist as CEO
Diagnostics Personnel

HSMN NewsFeed - 16 Nov 2015
First US Commercial Appointment: Atlas Genetics Appoints Keith Stauffer as VP Sales & Marketing
Diagnostics Personnel

HSMN NewsFeed - 12 Nov 2015
Rosetta Provides Update on Performance Data and Launch of RosettaGX Reveal(TM) (Thyroid microRNA Classifier)
Diagnostics Personalized Medicine Oncology

HSMN NewsFeed - 3 Nov 2015
Castle Biosciences Announces the Appointment of Federico Monzon, M.D., FCAP as Chief Medical Officer
Diagnostics Oncology Personnel

HSMN NewsFeed - 2 Nov 2015
PDI Enters Definitive Agreement to Sell Its Commercial Services Business to Publicis Healthcare Communications Group
Diagnostics Acquisitions

HSMN NewsFeed - 28 Oct 2015
Personal Genome Diagnostics Secures $21.4 Million in Series A Financing Led By New Enterprise Associates
Diagnostics Oncology Venture Capital Personnel

HSMN NewsFeed - 22 Oct 2015
Immunexpress Appoints Dr. Roy Davis Chief Medical Officer
Diagnostics Personnel

HSMN NewsFeed - 15 Oct 2015
GenomeDx Biosciences Adds Tina Nova and Craig Johnson to Board of Directors
Diagnostics Personalized Medicine Oncology Personnel

HSMN NewsFeed - 7 Oct 2015
Luminex Corporation Receives FDA Clearance for ARIES(R) System and ARIES(R) HSV 1&2 Assay
Diagnostics FDA

HSMN NewsFeed - 15 Sep 2015
Molecular Response Appoints the Former Head of Translational Medicine Oncology at MedImmune/AstraZeneca, Brett Hall, Ph.D., as Chief Executive Officer
Diagnostics Personnel

HSMN NewsFeed - 2 Sep 2015
Exosome Diagnostics Raises $17.6 Million in Second Round Series B Financing
Diagnostics Venture Capital

HSMN NewsFeed - 2 Sep 2015
Ascletis Secures US$35 Million Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 17 Aug 2015
Veracyte, Inc. Appoints Dr. Neil M. Barth as Chief Medical Officer
Diagnostics Oncology Personnel

HSMN NewsFeed - 3 Aug 2015
Orasure Technologies Receives FDA Emergency Use Authorization for Ebola Rapid Diagnostic Test
Diagnostics FDA

HSMN NewsFeed - 27 Jul 2015
Castle Biosciences Closes $11.7 Million Tranche of $20 Million Financing
Diagnostics Oncology Venture Capital

HSMN NewsFeed - 20 Jul 2015
Applied Proteomics Appoints Robert C. Verfurth as Vice President, Sales
Diagnostics Personalized Medicine Personnel

HSMN NewsFeed - 16 Jul 2015
Alere Receives FDA CLIA Waiver for Alere(TM) i Strep A Rapid Molecular Test
Diagnostics FDA

HSMN NewsFeed - 15 Jul 2015
OncoCyte Announces Appointment of Andy Arno to Board of Directors
Diagnostics Oncology Personnel

HSMN NewsFeed - 14 Jul 2015
Biocept Launches Diagnostic Assay for BRAF Mutations in Patients with Melanoma
Diagnostics Personalized Medicine Oncology Product Launch

HSMN NewsFeed - 6 Jul 2015
Darin Leigh Joins Metabolon as Chief Commercial Officer
Diagnostics Personnel

HSMN NewsFeed - 22 Jun 2015
Histogenics Corporation Announces Appointment of New Chief Financial Officer
Devices Regenerative Medicine Orthopaedic Personnel

HSMN NewsFeed - 16 Jun 2015
William Annett Named Chief Executive Officer of OncoCyte Corporation
Diagnostics Oncology Personnel

HSMN NewsFeed - 11 Jun 2015
Biontech Launches Mammatyper(R) Breast Cancer Diagnostic Test in Europe
Diagnostics Personalized Medicine Oncology Product Launch

HSMN NewsFeed - 29 May 2015
Myriad Presents New myRisk(TM) Hereditary Cancer Data at 2015 ASCO Annual Meeting
Diagnostics Oncology

HSMN NewsFeed - 26 May 2015
Roche receives FDA clearance for the cobas(R) Cdiff Test to detect Clostridium difficile
Diagnostics FDA

HSMN NewsFeed - 14 May 2015
OncoCyte Corporation Completes Equity Financing Round
Diagnostics Oncology Venture Capital

HSMN NewsFeed - 11 May 2015
Roche Receives FDA Approval for cobas(R) KRAS Mutation Test
Diagnostics Oncology FDA

HSMN NewsFeed - 22 Apr 2015
Great Basin Receives FDA 510(k) Clearance for Group B Strep Molecular Diagnostic Test
Diagnostics FDA

HSMN NewsFeed - 3 Apr 2015
Bruker Announces FDA Clearance for Second, Expanded Claim for the MALDI Biotyper CA System
Diagnostics FDA

HSMN NewsFeed - 31 Mar 2015
Tyrogenex, Xcovery Appoint Michael Webb as President and Chief Executive Officer
Biopharmaceuticals Ophthalmology Oncology Personnel

HSMN NewsFeed - 26 Feb 2015
Meridian Bioscience Receives CE Marking for Two New Molecular Amplification Tests: illumigene(R) Chlamydia and illumigene(R) Gonorrhea
Diagnostics Regulatory

HSMN NewsFeed - 19 Feb 2015
Lifecode Receives CAP Accreditation, Discloses $20.5M Series A-Round Funding Led By Sequoia Capital, the Mayo Clinic and Mayo Ventures
Diagnostics Oncology Venture Capital

HSMN NewsFeed - 18 Feb 2015
Biodesix Builds on Investments in Sales, Reimbursement and Government Affairs Growth Strategy
Diagnostics Personnel

HSMN NewsFeed - 11 Feb 2015
Xagenic Hires Vice President of Product Development to Expand Molecular Diagnostic Offerings and Speed Pipeline-to-Market
Diagnostics Personnel

HSMN NewsFeed - 5 Feb 2015
Roka Bioscience Strengthens Management Team to Drive Growth
Diagnostics Personnel

HSMN NewsFeed - 26 Jan 2015
Roche receives FDA clearance for next generation cobas MRSA/SA Test
Diagnostics FDA

HSMN NewsFeed - 20 Jan 2015
Akers Expands U.S. Sales Efforts With Key Leadership Additions
Diagnostics Personnel

HSMN NewsFeed - 9 Jan 2015
bioTheranostics Appoints Key Executives to Leadership Team
Diagnostics Personalized Medicine Oncology Personnel

HSMN NewsFeed - 8 Jan 2015
Myriad Obtains CE Mark for Tumor BRACAnalysis CDx(TM) and Launches Test in Europe as Companion Diagnostic for PARP Inhibitors
Diagnostics Oncology Regulatory

HSMN NewsFeed - 2 Jan 2015
Exact Sciences: Additional Update on CMS Reimbursement for Cologuard(R)
Diagnostics Reimbursement

HSMN NewsFeed - 29 Dec 2014
Roche receives FDA Emergency Use Authorization for the LightMix(R) Ebola Zaire rRT-PCR Test
Diagnostics

HSMN NewsFeed - 2 Dec 2014
Study Shows Prolaris(R) Could Save Healthcare System $6 Billion Over 10 Years
Diagnostics Urology Oncology

HSMN NewsFeed - 1 Dec 2014
Cepheid Receives FDA Clearance for Xpert Norovirus, the First On-Demand Molecular Test for Detection of Norovirus
Diagnostics FDA

HSMN NewsFeed - 19 Nov 2014
Crescendo Bioscience Highlights New Clinical Data on Vectra(R) DA at ACR
Diagnostics

HSMN NewsFeed - 18 Nov 2014
AdvanDx Receives FDA 510(k) Clearance for mecA XpressFISH(TM)
Diagnostics FDA

HSMN NewsFeed - 7 Nov 2014
Myriad myPath(TM) Melanoma Improves Diagnosis and Treatment Plans
Diagnostics Dermatology Oncology

HSMN NewsFeed - 24 Oct 2014
Myriad Establishes Tumor BRACAnalysis CDx(TM) Laboratory in Europe
Diagnostics Oncology

HSMN NewsFeed - 6 Oct 2014
bioTheranostics Appoints Nicolas Barthelemy as President and CEO
Diagnostics Oncology Personnel

HSMN NewsFeed - 9 Sep 2014
Myriad myPath(TM) Melanoma Test Reduced Indeterminate Cases by 76 Percent and Changed Treatment in 35 Percent of Cases
Diagnostics Oncology

HSMN NewsFeed - 18 Aug 2014
Rosetta Genomics Expands Management Team With Appointment of Douglas Sites as Executive Vice President of Sales and Marketing
Diagnostics Personnel

HSMN NewsFeed - 13 Aug 2014
Castle Biosciences Announces $11.8 Million Financing
Diagnostics Venture Capital

HSMN NewsFeed - 12 Aug 2014
FDA Approves Exact Sciences' Cologuard(R); First and Only Stool DNA Noninvasive Colorectal Cancer Screening Test
Diagnostics Oncology FDA

HSMN NewsFeed - 28 Jul 2014
Quidel Receives FDA Clearance for Its Hand-Held Molecular Diagnostic Test for Group A Strep
Diagnostics FDA

HSMN NewsFeed - 28 Jul 2014
New Chlamydia and Gonorrhea Assays on the BD Viper(TM) LT System Receive FDA 510k Clearance
Diagnostics FDA

HSMN NewsFeed - 7 Jul 2014
Provista Diagnostics, Inc. Appoints Rao V. Mulpuri, PhD, MBA, as Chief Operating Officer
Diagnostics Personnel

HSMN NewsFeed - 2 Jun 2014
Myriad myPath(TM) Melanoma Test Improves the Reliability of Melanoma Diagnosis
Diagnostics Dermatology Oncology

HSMN NewsFeed - 2 Jun 2014
Myriad Presents Clinical Data on Myriad myRisk(TM) Hereditary Cancer Test at ASCO
Diagnostics Oncology

HSMN NewsFeed - 29 May 2014
Islet Sciences, Inc. Appoints Steven Delmar as Chief Financial Officer
Biopharmaceuticals Endocrinology Personnel

HSMN NewsFeed - 7 May 2014
The BD MAX(TM) Enteric Bacterial Panel Receives FDA Clearance to Detect the Most Common Causes of Bacterial Gastroenteritis
Diagnostics FDA

HSMN NewsFeed - 6 May 2014
Myriad and UnitedHealthcare Sign Three-Year Agreement Making myRisk(TM) Hereditary Cancer Test Available to United Members
Diagnostics Oncology

HSMN NewsFeed - 1 May 2014
Myriad to Launch EndoPredict(R) in Canada
Diagnostics Oncology Personalized Medicine

HSMN NewsFeed - 16 Apr 2014
Provista Diagnostics Secures $6MM Series B Financing
Diagnostics Oncology Venture Capital

HSMN NewsFeed - 9 Apr 2014
CardioDx and Medison Israel Enter Into an Exclusive Corus(R) CAD Product Marketing and Sales Agreement
Diagnostics Cardiology Distribution

HSMN NewsFeed - 9 Apr 2014
Patrick Roche, Ph.D. Joins HTG Molecular Diagnostics
Diagnostics Personnel

HSMN NewsFeed - 21 Mar 2014
Exact Sciences Announces Appointment of Kevin Conroy as Chairman of the Board; David Thompson to Serve as Lead Independent Director
Diagnostics Oncology Personnel

HSMN NewsFeed - 17 Mar 2014
Veracyte, Inc. Appoints Julie A. Brooks as Executive Vice President, General Counsel and Secretary; and Andy Thorson as Executive Vice President, Corporate Strategy and Business Development
Diagnostics Personnel

HSMN NewsFeed - 13 Mar 2014
CombiMatrix Announces Partnership With American Pathology Partners to Provide Products of Conception Testing
Diagnostics

HSMN NewsFeed - 12 Mar 2014
Rosetta Genomics Provides Product Pipeline Update
Diagnostics

HSMN NewsFeed - 11 Mar 2014
Exosome Diagnostics Raises $27 Million in Series B Financing
Diagnostics Venture Capital

HSMN NewsFeed - 10 Mar 2014
CombiMatrix Hires R. Weslie Tyson, M.D., as Chief Medical Officer
Diagnostics Personnel

HSMN NewsFeed - 5 Mar 2014
Immunexpress Closes USD 6 Million Financing Round led by Debiopharm Group(TM)
Diagnostics Venture Capital

HSMN NewsFeed - 4 Mar 2014
Contextual Genomics Appoints Chris Wagner as President & CEO
Diagnostics Oncology Cardiology Personnel

HSMN NewsFeed - 3 Mar 2014
Myriad Publishes Clinical Utility Study for Prolaris(R)
Diagnostics Urology

HSMN NewsFeed - 26 Feb 2014
Nodality, Inc. Appoints Ralph Snyderman, M.D., to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Feb 2014
Rosetta Genomics Appoints Kevin Watson as Director, Reimbursement-Managed Care
Diagnostics Oncology Reimbursement Personnel

HSMN NewsFeed - 17 Feb 2014
Published Study Validates Agendia�s MammaPrint Test for Long-Term Prediction of Breast Cancer Outcome
Diagnostics Oncology

HSMN NewsFeed - 7 Feb 2014
BRCA Patent Owners and Gene by Gene, Ltd. Resolve Patent Suit
Diagnostics Oncology Litigation

HSMN NewsFeed - 29 Jan 2014
Myriad's Prolaris(R) Test Significantly Modifies Treatment Decisions for Patients With Prostate Cancer
Diagnostics Oncology

HSMN NewsFeed - 21 Jan 2014
Affymetrix Receives FDA Clearance of First-of-its-kind Postnatal Test for Developmental Delays and Intellectual Disabilities in Children
Diagnostics FDA

HSMN NewsFeed - 17 Jan 2014
Sequenom Laboratories grants Nicox exclusive promotion and marketing rights for its RetnaGene(TM) AMD test in North America
Diagnostics Ophthalmology Licensing

HSMN NewsFeed - 16 Jan 2014
MEDITE Signs Exclusive Marketing and Distribution Agreement With Medline
Diagnostics Distribution

HSMN NewsFeed - 13 Jan 2014
Arno Therapeutics Expands Management Team With Additions of Two Scientific Leaders
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 7 Jan 2014
Guided Therapeutics Names Gene Cartwright as Chief Executive Officer
Devices Diagnostics Oncology Personnel

HSMN NewsFeed - 30 Dec 2013
Quidel Receives FDA Clearance for Its Hand-Held Molecular Diagnostic Test - AmpliVue(R) Group B Strep Assay
Diagnostics FDA

HSMN NewsFeed - 19 Dec 2013
Cancer Genetics, Inc. Strengthens Its Diagnostics Sales Team With Seasoned Industry Leader
Diagnostics Oncology Personnel

HSMN NewsFeed - 18 Dec 2013
Lineagen Announces $3.5 Million Series C Round and Close of Series B Financing
Diagnostics Personalized Medicine Venture Capital

HSMN NewsFeed - 12 Dec 2013
Myriad myRisk Hereditary Cancer(TM) Test Significantly Improves Detection of Women at Risk for Hereditary Cancer by 51 Percent
Diagnostics Oncology

HSMN NewsFeed - 9 Dec 2013
Regado Biosciences Strengthens Executive Leadership
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Dec 2013
Myriad Genetics Announces Cancer Research Collaboration With Janssen
Diagnostics Oncology

HSMN NewsFeed - 5 Dec 2013
Cerner and Claritas Genomics Will Collaborate to Advance Personalized Medicine
Diagnostics Personalized Medicine

HSMN NewsFeed - 4 Dec 2013
Myriad's Prolaris(R) Test Guides Treatment Decisions for Men with Prostate Cancer
Diagnostics Urology Oncology

HSMN NewsFeed - 2 Dec 2013
Biodesix Closes Series E Financing
Diagnostics Personalized Medicine Venture Capital

HSMN NewsFeed - 19 Nov 2013
Applied Proteomics Appoints Premal S. Shah As Vice President Of Business Development
Diagnostics Personalized Medicine Personnel

HSMN NewsFeed - 12 Nov 2013
Myriad Genetics Launches myPath(TM) Melanoma Diagnostic Test
Diagnostics Oncology Product Launch

HSMN NewsFeed - 7 Nov 2013
Ariosa Diagnostics Appoints Dan Puckett as Chief Financial Officer and Dr. Thomas Musci as Chief Medical Officer
Diagnostics Personnel

HSMN NewsFeed - 29 Oct 2013
Myriad myPlan(TM) Lung Cancer Test Launched to Leading Oncologists
Diagnostics Oncology Product Launch

HSMN NewsFeed - 28 Oct 2013
Myriad myPlan(TM) Lung Cancer Test Meets Primary Endpoint in Validation Study
Diagnostics Oncology

HSMN NewsFeed - 24 Oct 2013
Myriad myRisk(TM) Hereditary Cancer Test Is Highly Accurate in Key Validation Study
Diagnostics Oncology

HSMN NewsFeed - 22 Oct 2013
BioReference Laboratories, Inc. Sued by Myriad Genetics, Confident in Its Position
Diagnostics Oncology Litigation

HSMN NewsFeed - 14 Oct 2013
IntegraGen Obtains Exclusive License for MicroRNA Which Predicts Therapy Outcomes in Metastatic Colorectal Cancer
Diagnostics Oncology Licensing

HSMN NewsFeed - 14 Oct 2013
Gregory L. Weaver Joins Atossa Genetics' Board of Directors
Diagnostics Personnel

HSMN NewsFeed - 14 Oct 2013
Myriad's myPath(TM) Melanoma Test is Highly Effective in Verification Study
Diagnostics Oncology Dermatology

HSMN NewsFeed - 8 Oct 2013
MolecularHealth Continues to Grow Management Team with New Chief Commercial Officer
Diagnostics Personalized Medicine Oncology Personnel

HSMN NewsFeed - 7 Oct 2013
Kevin Hrusovsky Joins SynapDx Board of Directors
Diagnostics Neurology Venture Capital

HSMN NewsFeed - 1 Oct 2013
First urine-based cancer mutation monitoring test available from Trovagene
Diagnostics Oncology Product Launch

HSMN NewsFeed - 18 Sep 2013
Atossa Genetics Signs Distribution Agreement With McKesson Medical-Surgical
Diagnostics Oncology Distribution

HSMN NewsFeed - 16 Sep 2013
Quidel Receives Two FDA Clearances for Molecular Diagnostic Tests for Use on Life Technologies QuantStudio(TM) Dx
Diagnostics FDA

HSMN NewsFeed - 5 Sep 2013
Myriad Genetics Launches myRisk(TM) Hereditary Cancer Panel
Diagnostics Oncology Product Launch

HSMN NewsFeed - 27 Aug 2013
bioTheranostics Appoints Three Key Executives
Diagnostics Personalized Medicine Oncology Personnel

HSMN NewsFeed - 26 Aug 2013
GeneDx Introduces Advanced Genetic Test Panels for Inherited Cancer Including Breast and Colon Cancer
Diagnostics Oncology Product Launch

HSMN NewsFeed - 22 Aug 2013
diaDexus, Inc. Appoints Ralf Schoenbrunner to Senior Vice President, Research and Early Development
Diagnostics Cardiology Personnel

HSMN NewsFeed - 20 Aug 2013
Applied Proteomics Inc. Completes $28 Million Series C Financing
Diagnostics Venture Capital

HSMN NewsFeed - 19 Aug 2013
Provista Diagnostics Appoints Chief Commercial Officer
Diagnostics Personnel

HSMN NewsFeed - 15 Jul 2013
GeneNews Announces Management and Board Changes
Diagnostics Personalized Medicine Personnel

HSMN NewsFeed - 1 Jul 2013
Illumina Applies CE Mark to MiSeqDx(TM) Cystic Fibrosis System
Diagnostics Regulatory

HSMN NewsFeed - 27 Jun 2013
Cepheid Receives FDA Clearance For Updated Xpert MRSA/SA Blood Culture (BC) Test
Diagnostics FDA

HSMN NewsFeed - 25 Jun 2013
Multiplicom Appoints Dr. Ian Gilham as Chairman of the Board
Diagnostics Personnel

HSMN NewsFeed - 20 Jun 2013
Atossa Genetics Signs Distribution Agreement With Fisher HealthCare
Diagnostics Distribution

HSMN NewsFeed - 13 Jun 2013
Supreme Court Upholds Myriad's cDNA Patent Claims
Diagnostics Oncology Litigation

HSMN NewsFeed - 13 Jun 2013
GeneDx to Launch Comprehensive Breast Cancer Genetic Test
Diagnostics Oncology Product Launch

HSMN NewsFeed - 5 Jun 2013
Peter J. Carbonaro Joins Atossa Genetics as Senior Vice President of Operations
Diagnostics Personnel

HSMN NewsFeed - 12 Apr 2013
Veracyte Announces Appointment of Shelly D. Guyer as Chief Financial Officer
Diagnostics Personnel

HSMN NewsFeed - 27 Mar 2013
AdvanDx, Inc. Elects Former Roche Molecular Systems CEO, Heiner Dreismann, Ph.D., to its Board of Directors
Diagnostics Personnel

HSMN NewsFeed - 19 Mar 2013
bioTheranostics Adds Chief Medical Officer & Vice President of Medical, Clinical & Regulatory Affairs
Diagnostics Oncology Personnel

HSMN NewsFeed - 13 Mar 2013
Vermillion Appoints Thomas McLain as President and Chief Executive Officer
Diagnostics Oncology Personnel

HSMN NewsFeed - 12 Mar 2013
Allegro Diagnostics Announces BronchoGen(TM) Genomic Test for Improved Diagnosis of Lung Cancer Successfully Achieves Clinical Validation
Diagnostics Oncology

HSMN NewsFeed - 5 Mar 2013
Myriad's Prolaris(R) Test Predicts Risk of Prostate Cancer Recurrence in Fourth Peer Reviewed Study
Diagnostics Urology Oncology

HSMN NewsFeed - 4 Mar 2013
Trovagene Appoints Mark Erlander, Ph.D. as Chief Scientific Officer
Diagnostics Personnel

HSMN NewsFeed - 22 Feb 2013
Mark McDonough to Assume CEO Role at CombiMatrix
Diagnostics Personnel

HSMN NewsFeed - 23 Jan 2013
Strand Diagnostics appoints new President
Diagnostics Personnel

HSMN NewsFeed - 22 Jan 2013
Hologic Announces Organizational Changes to its Diagnostics Segment; Integration of Gen-Probe Proceeding Ahead of Schedule
Diagnostics Personnel

HSMN NewsFeed - 9 Jan 2013
Spinomix Closes a $ 3 Million Financing Round Led by Debiopharm Group
Diagnostics Venture Capital

HSMN NewsFeed - 4 Jan 2013
Predictive Biosciences Appoints Diagnostics Industry Veteran Pierre Cassigneul as Chief Executive Officer
Diagnostics Oncology Urology Personnel

HSMN NewsFeed - 27 Dec 2012
John Norris, JD, MBA Appointed CEO of Health Discovery Corporation
Diagnostics Personnel Personalized Medicine

HSMN NewsFeed - 21 Dec 2012
Christopher S. Destro Joins Atossa Genetics as Vice President of Sales and Marketing
Diagnostics Oncology Personnel

HSMN NewsFeed - 11 Dec 2012
Sequenom Announces Leadership Appointments
Diagnostics Personnel

HSMN NewsFeed - 28 Nov 2012
Trovagene to Introduce First Urine-Based Molecular Diagnostic Test for Transrenal Cancer Mutation Monitoring
Diagnostics Oncology

HSMN NewsFeed - 27 Nov 2012
Vermillion Appoints Bruce A. Huebner as Interim Chief Executive Officer
Diagnostics Oncology Personnel

HSMN NewsFeed - 19 Nov 2012
Abacus Diagnostica Receives CE Mark for its Rapid Direct PCR Test for Toxigenic Clostridium Difficile
Diagnostics Regulatory

HSMN NewsFeed - 16 Nov 2012
Saladax Biomedical, Inc. Appoints Mark D. Myslinski as Chief Commercial Officer
Diagnostics Personalized Medicine Oncology Personnel

HSMN NewsFeed - 13 Nov 2012
Nanosphere Receives FDA Clearance to Market Test for Detection of CYP2C19 Mutations Affecting Drug Metabolism
Diagnostics FDA

HSMN NewsFeed - 5 Nov 2012
Amedica Names Distinguished Health Care Industry Executive Jay M. Moyes To Board Of Directors
Devices Orthopaedic Neurosurgery Personnel

HSMN NewsFeed - 5 Nov 2012
Pathwork Diagnostics Inc. Appoints Lee McCracken as CEO
Diagnostics Oncology Personnel

HSMN NewsFeed - 24 Oct 2012
Abbott's ALK Test is Now Available in Europe as a Companion Diagnostic Test to Aid in Identifying Patients for Targeted Lung Cancer Therapy
Diagnostics Personalized Medicine Oncology

HSMN NewsFeed - 11 Oct 2012
Rosetta Genomics Expands Management Team With Chief Medical Officer and Chief Scientific Officer
Diagnostics Oncology Personalized Medicine Personnel

HSMN NewsFeed - 9 Oct 2012
Vaxxas Appoints David Hoey as Company�s First CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Oct 2012
Amedica Names Distinguished Orthopaedic Executive Eric K. Olson to Board of Directors
Devices Orthopaedic Neurosurgery Personnel

HSMN NewsFeed - 3 Oct 2012
StrataDx appoints Chief Financial Officer, Executive Vice President of Sales and Marketing, New Board Member
Diagnostics Personnel

HSMN NewsFeed - 1 Oct 2012
XDx Appoints Peter Maag as President and CEO
Diagnostics Personnel

HSMN NewsFeed - 25 Sep 2012
Gynecor, a Division of Bostwick Laboratories, Inc., Adds New State-of-the-Art Lab Technology to Help Physicians Identify Patients at Risk for Cervical Cancer, Improve Treatment Decisions
Diagnostics Oncology

HSMN NewsFeed - 24 Sep 2012
Nodality, Inc. Appoints Laura Brege as Chief Executive Officer
Personalized Medicine Personnel

HSMN NewsFeed - 13 Sep 2012
Transgenomic Announces Appointment of Mark P. Colonnese as Chief Financial Officer
Diagnostics Personalized Medicine Personnel

HSMN NewsFeed - 13 Sep 2012
Genetic Technologies Announces Key Managerial Appointment
Diagnostics Personnel

HSMN NewsFeed - 12 Sep 2012
GenMark Diagnostics Receives FDA Clearance for RVP Test
Diagnostics FDA

HSMN NewsFeed - 4 Sep 2012
Aushon BioSystems Appoints Martin Verhoef Chief Executive Officer
Diagnostics Personnel

HSMN NewsFeed - 23 Aug 2012
CombiMatrix Names Mark McDonough Chief Commercial Officer
Diagnostics Personnel

HSMN NewsFeed - 1 Aug 2012
Hologic Completes Acquisition Of Gen-Probe
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 25 Jul 2012
bioTheranostics Adds Chief Commercial Officer & VP of Corporate Development
Diagnostics Oncology Personalized Medicine Personnel

HSMN NewsFeed - 24 Jul 2012
Transgenomic Announces Medicare Coverage for Clopidogrel (Plavix(R)) Response Test
Diagnostics Cardiology Reimbursement

HSMN NewsFeed - 20 Jul 2012
Quanterix Appoints Paul Chapman as President and Chief Executive Officer
Diagnostics Personnel

HSMN NewsFeed - 17 Jul 2012
Biodesix Appoints Vice President of Clinical Development & Medical Affairs
Diagnostics Personalized Medicine Personnel

HSMN NewsFeed - 17 Jul 2012
Hologic and Gen-Probe Announce Clearance from German Federal Cartel Office for Hologic's Acquisition of Gen-Probe
Devices Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 10 Jul 2012
Agendia Welcomes Dr. Mark Gittleman to Expanding Medical Advisory Board
Diagnostics Personalized Medicine Oncology Personnel

HSMN NewsFeed - 9 Jul 2012
Agendia Names Industry Veteran Glen Fredenberg CFO and Vice President of Finance
Diagnostics Personalized Medicine Oncology Personnel

HSMN NewsFeed - 6 Jul 2012
Court Denies Preliminary Injunction Motion Against Ariosa Diagnostics
Diagnostics Litigation

HSMN NewsFeed - 26 Jun 2012
Allegro Diagnostics Appoints Clinical and Scientific Advisory Board Comprised of Experts in Pulmonology, Lung Cancer and Molecular Diagnostics
Diagnostics Oncology Personnel

HSMN NewsFeed - 26 Jun 2012
Caris Life Sciences Launches Caris Target Now(TM) Select for NSCLC, Melanoma, and Cancers of the Breast, Colon, and Ovary
Diagnostics Oncology

HSMN NewsFeed - 14 Jun 2012
GenMark Diagnostics Appoints Stephen T. Worland, Ph.D. to Board of Directors
Diagnostics Personalized Medicine Personnel

HSMN NewsFeed - 1 Jun 2012
Agendia Announces Launch of ColoPrint for Colon Cancer Prognosis and Prediction
Diagnostics Personalized Medicine Oncology

HSMN NewsFeed - 24 May 2012
Cepheid Receives FDA Clearance for GeneXpert Infinity-80 System for Initial Use with Xpert Flu Assay
Diagnostics FDA

HSMN NewsFeed - 21 May 2012
GenVec Appoints Cynthia Collins as President and CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 May 2012
LaserGen names Dr. Mimi Healy as CEO
Diagnostics Personnel

HSMN NewsFeed - 8 May 2012
FDA Clears Gen-Probe's PANTHER(R) System for use with APTIMA Combo 2(R) Assay
Diagnostics FDA

HSMN NewsFeed - 1 May 2012
Dr. Carlo Croce joins Trovagene as Scientific Consultant and Member of the Company's Scientific Advisory Board
Diagnostics Personnel

HSMN NewsFeed - 30 Apr 2012
Hologic to Acquire Gen-Probe
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 23 Apr 2012
Keith McCormick Joins Trovagene, Inc. as Head of Commercial Operations
Diagnostics Personnel

HSMN NewsFeed - 17 Apr 2012
Abbott Licenses Biomarkers for Use in Differentiating Aggressive from Nonaggressive Prostate Cancer
Diagnostics Personalized Medicine Oncology Licensing

HSMN NewsFeed - 17 Apr 2012
QIAGEN Receives FDA Clearances for Rotor-Gene Q MDx Instrument and Compatible Influenza A/B Assay
Diagnostics FDA

HSMN NewsFeed - 5 Apr 2012
Richard T. Kloos, M.D., Joins Veracyte as Senior Medical Director
Diagnostics Personnel

HSMN NewsFeed - 4 Apr 2012
FDA Sets Date for Advisory Committee Review of OraSure Over-the-Counter Rapid HIV Test
Diagnostics HIV/AIDS FDA

HSMN NewsFeed - 2 Apr 2012
Good Start Genetics Announces $14M Series B Financing, Expands Senior Management Team
Diganostics Venture Capital Personnel

HSMN NewsFeed - 2 Apr 2012
MolecularMD Closes $6 Million Series B Financing and Announces Ensuing Growth Initiatives
Diagnostics Venture Capital

HSMN NewsFeed - 28 Mar 2012
Kapil Dhingra, Former Head of Roche Oncology, Joins Exosome Diagnostics Board of Directors
Diagnostics Personalized Medicine Oncology Personnel

HSMN NewsFeed - 22 Mar 2012
First-Ever Prospective Diagnostic Study in Breast Cancer
Diagnostics Oncology

HSMN NewsFeed - 15 Mar 2012
Quest Diagnostics Launches First Molecular Test for Kidney Organ Transplant Rejection
Diagnostics

HSMN NewsFeed - 14 Mar 2012
Everist Genomics Develops World's First Comprehensive Companion Diagnostics and Prognostics Portfolio for Early Diagnosis and Improved Treatment of Colorectal Cancer
Diagnostics Personalized Medicine Oncology

HSMN NewsFeed - 6 Mar 2012
Abbott and Merck Collaborate to Develop Companion Diagnostic Test for Investigational Cancer Therapy
Diagnostics Personalized Medicine Oncology

HSMN NewsFeed - 22 Feb 2012
Integrated Diagnostics(R) Secures $10 Million Third Tranche of Series A Financing
Diagnostics Venture Capital

HSMN NewsFeed - 20 Feb 2012
Plexxikon Announces European Approval of Zelboraf(R) for the Treatment of Patients With BRAF Mutation-Positive Metastatic Melanoma
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 16 Feb 2012
GenMark Diagnostics Appoints Dr. Jorge Garces Senior Vice President, Research and Development
Diagnostics Personnel

HSMN NewsFeed - 15 Feb 2012
FDA Approves Gen-Probe's PROGENSA(R) PCA3 Assay, First Urine-Based Molecular Test to Help Determine Need for Repeat Prostate Biopsies
Diagnostics FDA

HSMN NewsFeed - 14 Feb 2012
Atossa Genetics, Inc. Announces Filing of S-1 Registration Statement
Diagnostics

HSMN NewsFeed - 10 Feb 2012
Stephen Zaniboni Joins Trovagene, Inc. as Chief Financial Officer
Diagnostics Personalized Medicine Personnel

HSMN NewsFeed - 2 Feb 2012
Ronnie Andrews Joins Life Technologies as President, Medical Sciences
Diagnostics Personnel

HSMN NewsFeed - 24 Jan 2012
Leading Private Venture Capital Firms Invest $45 Million in Mevion Medical Systems
Devices Oncology Venture Capital

HSMN NewsFeed - 20 Jan 2012
Genzyme and Veracyte Announce Global Co-Promotion Agreement to Deliver Personalized Solution for Thyroid Patients
Diagnostics Endocrinology Oncology Personalized Medicine

HSMN NewsFeed - 10 Jan 2012
Interwest Partners Expands Medical Devices Team
Devices Venture Capital Personnel

HSMN NewsFeed - 9 Jan 2012
BG Medicine, Inc. Appoints Eric Bouvier as Chief Executive Officer
Diagnostics Personnel

HSMN NewsFeed - 22 Dec 2011
Response Genetics Names Thomas A. Bologna Chairman and CEO
Diagnostics Personnel

HSMN NewsFeed - 20 Dec 2011
Todd R. Nelson Ph.D. Named President & Chief Executive Officer of MP Biomedicals
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 Dec 2011
Myriad Genetics Presents BRACAnalysis(R) Cost-Effectiveness Study at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium
Diagnostics Oncology

HSMN NewsFeed - 7 Dec 2011
Antonius Schuh, Ph.D. Joins TrovaGene, Inc. As Chief Executive Officer
Diagnostics Personnel

HSMN NewsFeed - 6 Dec 2011
Agendia Introduces the SYMPHONY(TM) Breast Cancer Profile With Paraffin Embedded Tissue
Diagnostics Personalized Medicine Oncology

HSMN NewsFeed - 6 Dec 2011
Spectros Corporation Signs Distribution Agreements in Middle East
Devices Monitoring Distribution

HSMN NewsFeed - 15 Nov 2011
Sera Prognostics Secures $19.3 Million Series A Funding to Commercialize Preterm Birth Predictor; Appoints Gregory C. Critchfield, MD as Chief Executive Officer
Diagnostics Venture Capital Personnel

HSMN NewsFeed - 14 Nov 2011
ThermalTherapeutic Systems, Inc. Names Gardiner F. H. Smith, President and Chief Executive Officer
Devices Personnel

HSMN NewsFeed - 8 Nov 2011
Pat Noland Appointed StrataDx Chief Executive Officer
Diagnostics Personnel

HSMN NewsFeed - 31 Oct 2011
FDA Approves Gen-Probe's APTIMA(R) HPV Assay, New Molecular Test to Detect Virus that Causes Cervical Cancer
Diagnostics Oncology FDA

HSMN NewsFeed - 24 Oct 2011
Abbott's Genetic Test for Acute Myeloid Leukemia Prognosis Cleared by FDA
Diagnostics FDA

HSMN NewsFeed - 19 Oct 2011
Abbott to Separate into Two Leading Companies in Diversified Medical Products and Research-Based Pharmaceuticals
Biopharmaceuticals Devices Diagnostics

HSMN NewsFeed - 14 Oct 2011
Health Discovery Corporation Agrees with the U.S. Preventive Services Task Force�s Position Against PSA-Based Screening for Prostate Cancer and Believes Its Four-Gene Assay for Prostate Cancer is the Best Alternative to PSA
Diagnostics Personalized Medicine Oncology

HSMN NewsFeed - 5 Oct 2011
Spectros T-Stat Shown to Be Earliest Available Method for Detection of Surgical Skin Flap Compromise After Surgery
Devices Surgery Monitoring

HSMN NewsFeed - 22 Sep 2011
Life Technologies Signs Agreement with Quidel to Distribute and Commercialize Diagnostic Assays in Europe
Diagnostics Distribution

HSMN NewsFeed - 7 Sep 2011
TrovaGene, Inc., Announces Worldwide Exclusive Licensing of Assay for Hairy Cell Leukemia
Diagnostics Licensing Oncology

HSMN NewsFeed - 26 Aug 2011
Abbott Receives FDA Approval for ALK Gene Test for Lung Cancer Therapy Selection
Diagnostics Personalized Medicine Oncology FDA

HSMN NewsFeed - 23 Aug 2011
IQuum Receives FDA 510(k) Clearance for Liat(TM) Influenza A/B Assay for Influenza Molecular Diagnostics in Approximately 20 Minutes
Diagnostics FDA

HSMN NewsFeed - 22 Aug 2011
FDA Clears Abbott's Genetic FISH Panel for Leukemia Patient Prognosis
Diagnostics Oncology FDA

HSMN NewsFeed - 25 Jul 2011
Response Genetics Announces Search for New CEO
Diagnostics Personnel

HSMN NewsFeed - 25 Jul 2011
St. Gallen International Breast Cancer Expert Panel Guidelines Include Oncotype DX(R) as Predictor of Chemotherapy Benefit
Diagnostics Personalized Medicine Oncology

HSMN NewsFeed - 13 Jun 2011
Spectros Corporation Introduces Continuum(R), a Broadband Infrared Sensor for Brain and Gut Oximetry
Devices Monitoring

HSMN NewsFeed - 3 Jun 2011
Breast Cancer Genomic Test Shown to Predict Patient Survival Following Adjuvant Chemotherapy
Diagnostics Personalized Medicine Oncology

HSMN NewsFeed - 19 May 2011
Vermillion Announces the Appointment of Bruce Huebner to its Board of Directors
Diagnostics Personnel

HSMN NewsFeed - 18 May 2011
Abbott Receives FDA Approval for Molecular Test for Hepatitis C
Diagnostics FDA

HSMN NewsFeed - 18 May 2011
Molecular Response Appoints Kenna Anderes, PhD, as Senior Vice President of Translational Medicine
Diagnostics Personnel

HSMN NewsFeed - 2 May 2011
HTG Molecular Diagnostics Appoints John Lubniewski to Chief Business Officer
Diagnostics Personnel

HSMN NewsFeed - 20 Apr 2011
Mersana Therapeutics Appoints Michael A. Metzger as EVP & COO
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Apr 2011
Rosetta Genomics Names Brian Markison Board Chairman
Diagnostics Personalized Medicine Personnel

HSMN NewsFeed - 7 Apr 2011
MEDomics Announces a Growth Capital Investment from SpaGus Ventures LLC and Gary Augusta Joins MEDomics as Chief Operating Officer
Personalized Medicine Personnel Venture Capital

HSMN NewsFeed - 6 Apr 2011
GenMark Diagnostics Appoints Hany Massarany President and Chief Executive Officer
Diagnostics Personalized Medicine Personnel

HSMN NewsFeed - 4 Apr 2011
Tobira Therapeutics Appoints Andrew Hindman President and Chief Executive Officer
Biopharmaceuticals HIV/AIDS Personnel

HSMN NewsFeed - 23 Mar 2011
Asuragen Launches CE Marked IVD AmplideX(TM) Fragile X Test in Europe
Diagnostics Regulatory

HSMN NewsFeed - 18 Mar 2011
Quest Diagnostics to Acquire Celera, Strengthening Position as World's Leading Innovator in Molecular Diagnostics and Development
Diagnostics Personalized Medicine Mergers & Acquisitions

HSMN NewsFeed - 11 Feb 2011
Hologic Receives FDA Approval for First 3-D Digital Mammography (Breast Tomosynthesis) System
Devices Radiology FDA

HSMN NewsFeed - 8 Feb 2011
Hologic Targets Women's Health Professionals at ECR 2011
Devices Radiology Oncology

HSMN NewsFeed - 1 Feb 2011
Soligenix Appoints Kevin Horgan, MD, as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Jan 2011
Genoptix Announces Agreement to be Acquired by Novartis
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 19 Jan 2011
Genentech Personalized Investigational Medicine Shows Survival Benefit in Advanced Skin Cancer
Biopharmaceuticals Diagnostics Personalized Medicine

HSMN NewsFeed - 18 Jan 2011
Diagnoplex Closes an Extension of its Series A Financing With a Substantial Investment by Debiopharm Group(TM)
Diagnostics Personalized Medicine Venture Capital

HSMN NewsFeed - 17 Jan 2011
AdvanDx Receives FDA 510(k) Clearance for GNR Traffic Light(TM) PNA FISH(R)
Diagnostics Personalized Medicine FDA

HSMN NewsFeed - 13 Jan 2011
Nanosphere Receives FDA Clearance for Respiratory Virus Subtyping Test Panel
Diagnostics FDA

HSMN NewsFeed - 11 Jan 2011
EraGen Appoints Gregory D. Rodgers Vice President of Manufacturing
Diagnostics Personnel

HSMN NewsFeed - 7 Jan 2011
Hologic Acquires Interlace Medical
Devices Surgery Mergers & Acquisitions

HSMN NewsFeed - 6 Jan 2011
BioCardia elects Industry Veteran, Jay M. Moyes, to Board of Directors
Devices Regenerative Medicine Cardiology Personnel

HSMN NewsFeed - 20 Dec 2010
Myriad Genetics Launches PANEXIA, New Predictive Test for Hereditary Pancreatic and Related Cancers
Diagnostics Oncology

HSMN NewsFeed - 20 Dec 2010
Brian Markison to Join Rosetta Genomics Board of Directors
Diagnostics Personnel

HSMN NewsFeed - 20 Dec 2010
LDR Spine Welcomes Mr. Joe Ross as Vice President of U.S. Marketing
Devices Orthopaedic Neurosurgery Personnel

HSMN NewsFeed - 10 Dec 2010
Advanced BioHealing Appoints Kevin C. O'Boyle as Chief Financial Officer
Regenerative Medicine Personnel

HSMN NewsFeed - 9 Dec 2010
CombiMatrix Receives Acceptance Notice for Listing on the Nasdaq Capital Market; Hires New Director of Sales
Diagnostics Personnel

HSMN NewsFeed - 8 Dec 2010
Myriad Acquires Novel Technology From Melanoma Diagnostics
Diagnostics Oncology Acquisitions

HSMN NewsFeed - 8 Dec 2010
Prodesse ProAdeno+ Assay Cleared for US Marketing by FDA
Diagnostics FDA

HSMN NewsFeed - 8 Dec 2010
Sequenta, Inc. Secures $13 Million in Series B Financing
Diagnostics Venture Capital

HSMN NewsFeed - 23 Nov 2010
Hologic Receives FDA Approvable Letter for Selenia Dimensions (3-D) Digital Mammography Tomosynthesis System
Devices Radiology Oncology FDA

HSMN NewsFeed - 19 Nov 2010
VeriStrat(R) Test Identifies Lung Cancer Patients Benefiting from Combination Therapy
Diagnostics Personalized Medicine Oncology

HSMN NewsFeed - 5 Nov 2010
Metamark Genetics, Inc. Announces New Chief Executive Officer
Diagnostics Personnel

HSMN NewsFeed - 26 Oct 2010
Response Genetics, Inc. Announces Departure of Chief Operating Officer
Diagnostics Oncology Personnel

HSMN NewsFeed - 26 Oct 2010
Myriad and Abbott Enter Into Cooperative Agreement
Diagnostics Oncology

HSMN NewsFeed - 22 Oct 2010
GE Healthcare to Acquire Cancer Diagnostic Company Clarient Inc.
Diagnostics Personalized Medicine Mergers & Acquisitions

HSMN NewsFeed - 6 Oct 2010
Pathwork Diagnostics Completes $30M Series C Round
Diagnostics Personalized Medicine Venture Capital

HSMN NewsFeed - 29 Sep 2010
Quidel Announces FDA Clearance of Its QuickVue(R) RSV 10 Immunoassay Diagnostic Test
Diagnostics FDA

HSMN NewsFeed - 28 Sep 2010
Predictive Biosciences Appoints New Members to Leadership Team
Diagnostics Oncology Urology Personnel

HSMN NewsFeed - 27 Sep 2010
Positive Reimbursement Coverage Issued for RedPath's PathFinderTG(R) Technology
Diagnostics Oncology Reimbursement

HSMN NewsFeed - 24 Sep 2010
Hologic's Selenia Dimensions (3-D) Digital Mammography Tomosynthesis System Receives Favorable Votes From FDA Advisory Panel
Devices Radiology Oncology FDA

HSMN NewsFeed - 22 Sep 2010
Roche Receives FDA Approval for Second-Generation Hepatitis B Viral Load Test
Diagnostics FDA

HSMN NewsFeed - 20 Sep 2010
Molecular Response Announced Today the Appointment of Cyrus K. Mirsaidi to Chief Executive Officer
Diagnostics Personalized Medicine Personnel

HSMN NewsFeed - 20 Sep 2010
Celera Signs Agreement with Abbott for Distribution of CE-marked KIF6 Test to Identify Patients at Risk of Coronary Heart Disease
Diagnostics Cardiology Distribution

HSMN NewsFeed - 16 Sep 2010
Metamark Genetics, Inc. Announces New Chief Scientific Officer
Diagnostics Personalized Medicine Oncology Personnel

HSMN NewsFeed - 15 Sep 2010
Saladax Biomedical Adds Industry Expert to Board of Directors
Diagnostics Personalized Medicine Personnel

HSMN NewsFeed - 8 Sep 2010
XDx Appoints New Vice President of Corporate Development and Legal Affairs
Diagnostics Personnel

HSMN NewsFeed - 31 Aug 2010
Quidel Announces FDA Clearance of Its RapidVue(R) hCG Pregnancy Lateral Flow Diagnostic Test
Diagnostics FDA

HSMN NewsFeed - 23 Jul 2010
Vermillion Announces Relocation of Corporate Offices to Austin, Texas
Diagnostics

HSMN NewsFeed - 7 Jul 2010
K-V Pharmaceutical Company Announces the Election of New Independent Member to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Jun 2010
Abbott Receives FDA Clearance for Molecular Diagnostic Test for Detection of Chlamydia and Gonorrhea Infections
Diagnostics FDA

HSMN NewsFeed - 25 Jun 2010
Helicos BioSciences Announces Launch of Diagnostics Business
Diagnostics

HSMN NewsFeed - 16 Jun 2010
Predictive Biosciences Closes $25 Million Series C Financing
Diagnostics Oncology Venture Capital

HSMN NewsFeed - 10 Jun 2010
Response Genetics, Inc. Announces Appointment of Chief Operating Officer
Diagnostics Personnel

HSMN NewsFeed - 9 Jun 2010
Veracyte Completes $28 Million Series B Round - One Step Closer to Commercializing First Molecular Diagnostic Product
Diagnostics Oncology Venture Capital

HSMN NewsFeed - 8 Jun 2010
IncellDx Secures $3 Million in Series A Financing
Diagnostics Venture Capital

HSMN NewsFeed - 8 Jun 2010
Cepheid Receives FDA Clearance for Xpert SA Nasal Complete, the First Molecular Test for Simultaneous Detection and Differentiation of S. aureus & MRSA Colonization
Diagnostics FDA

HSMN NewsFeed - 4 Jun 2010
FDA Approves New Roche Dual-PCR Target HIV-1 Test
Diagnostics FDA HIV/AIDS

HSMN NewsFeed - 3 Jun 2010
EPEMED, the European Personalised Medicine Association, Appoints Executive Director
Personalized Medicine Diagnostics Personnel

HSMN NewsFeed - 26 May 2010
Predictive Biosciences Expands Leadership Team and Commercial Sales Force
Diagnostics Oncology Personnel

HSMN NewsFeed - 11 May 2010
Hologic Unveils Next Generation NovaSure Endometrial Ablation System
Devices

HSMN NewsFeed - 10 May 2010
AltheaDx Announces Appointment of New CEO and President and Adds Dr. Ann Kessler to the Board of Directors
Personalized Medicine Diagnostics Personnel

HSMN NewsFeed - 26 Apr 2010
Osmetech plc Receives 510(k) Clearance for the eSensor(R) Thrombophilia Risk Test
Diagnostics FDA

HSMN NewsFeed - 21 Apr 2010
Rheonix, Inc. Completes $12.6 Million Series A Financing
Diagnostics Venture Capital

HSMN NewsFeed - 31 Mar 2010
AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Candida Bloodstream Pathogens
Diagnostics FDA

HSMN NewsFeed - 30 Mar 2010
Hycor Biomedical Announces Appointment of Dick Aderman as President and CEO
Diagnostics Personnel

HSMN NewsFeed - 29 Mar 2010
Response Genetics Announces Resignation of Chief Financial Officer
Diagnostics Oncology Personnel

HSMN NewsFeed - 22 Mar 2010
Asuragen Appoints French Distributor Biomedical Diagnostics SA for Signature(R) Oncology Portfolio
Diagnostics Oncology Distribution

HSMN NewsFeed - 11 Mar 2010
Illumina and Glenn Close Announce the First Full Coverage DNA Sequencing of a Named Female
Diagnostics

HSMN NewsFeed - 8 Mar 2010
ThermalTherapeutic Systems Announces FDA Clearance of the VERATHERM(TM) Portable Hyperthermic Perfusion System
Devices FDA

HSMN NewsFeed - 3 Mar 2010
Abbott to Collaborate With GSK on Molecular Diagnostic Test to Select Candidate Patients for Future Skin Cancer Immunotherapy
Diagnostics Biopharmaceuticals Oncology

HSMN NewsFeed - 2 Mar 2010
Myriad Genetics Launches PROLARIS(TM): First Diagnostic Test to Predict Prostate Cancer Recurrence
Diagnostics Oncology

HSMN NewsFeed - 17 Feb 2010
Roche Collaborates with Merck on Developmental Test for Cancer-Related Gene Mutation
Diagnostics Oncology

HSMN NewsFeed - 11 Feb 2010
Abbott Receives U.S. FDA Approval for Heat-Stable Norvir(R) (ritonavir) Tablets
Biopharmaceuticals HIV/AIDS FDA

HSMN NewsFeed - 9 Feb 2010
Sequenom Licenses Worldwide Rights to Develop Age-Related Macular Degeneration Diagnostic Test
Diagnostics Ophthalmology Licensing

HSMN NewsFeed - 2 Feb 2010
Medco Acquires Leading Genetics Healthcare Company, DNA Direct
Diagnostics Personalized Medicine Mergers & Acquisitions

HSMN NewsFeed - 13 Jan 2010
Population Diagnostics, Inc. Appoints Dr. Peggy Eis as Chief Technology Officer
Diagnostics Personalized Medicine Personnel

HSMN NewsFeed - 6 Jan 2010
Cepheid Receives FDA Clearance for First Rapid and Accurate Surveillance Test for vanA the Resistance Gene Most Associated with Hospital-Acquired VRE Infections
Diagnostics FDA

HSMN NewsFeed - 4 Jan 2010
Cepheid Receives FDA Emergency Use Authorization (EUA) for First 2009 H1N1 Influenza Assay for CLIA 'Moderate Complexity' Laboratories
Diagnostics FDA

HSMN NewsFeed - 22 Dec 2009
AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Gram-Negative Bloodstream Pathogens
Diagnostics FDA

HSMN NewsFeed - 17 Dec 2009
DNA Direct Receives URAC Accreditation for Health Utilization Management
Diagnostics

HSMN NewsFeed - 16 Dec 2009
Caris Diagnostics Names New Vice Chairman and Board Member, Dr. Jonathan Knowles
Diagnostics Personnel

HSMN NewsFeed - 16 Dec 2009
Roche Licenses First-in-Class Treatments for Chronic Pain to Afferent Pharmaceuticals; Afferent Secures $23 Million in Series A Financing
Biopharmaceuticals Licensing Venture Capital

HSMN NewsFeed - 14 Dec 2009
FDA Grants Emergency Use Authorization for DxNA's GeneSTAT(TM) Integrated PCR-based Influenza Detection System for H1N1 Virus
Diagnostics FDA

HSMN NewsFeed - 10 Dec 2009
AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens
Diagnostics FDA

HSMN NewsFeed - 8 Dec 2009
Novartis Tasigna(R) Trial Shows Superior Results to Gleevec(R) in Patients With Early-Stage Chronic Myeloid Leukemia
Biopharmaceuticals Oncology

HSMN NewsFeed - 2 Dec 2009
FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus
Diagnostics FDA

HSMN NewsFeed - 18 Nov 2009
Asuragen Signs Development and Worldwide Distribution Agreement with Life Technologies
Diagnostics Oncology Distribution

HSMN NewsFeed - 5 Nov 2009
Cardiac Science Appoints Healthcare Executive Ronald A. Andrews, Jr. to Board of Directors
Devices Cardiology Monitoring Personnel

HSMN NewsFeed - 3 Nov 2009
Cancer Diagnostics Company, On-Q-ity, Raises $21M in Series A Funding for the Development of Technologies to Personalize Cancer Therapy
Diagnostics Oncology Venture Capital

HSMN NewsFeed - 29 Oct 2009
FDA Grants Emergency Use Authorization of the Prodesse ProFlu-ST(TM)
Diagnostics FDA

HSMN NewsFeed - 28 Oct 2009
MolecularMD Establishes New Operations Facility to Support Growth in Personalized Cancer Medicine Business
Diagnostics Oncology

HSMN NewsFeed - 27 Oct 2009
AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Enterococcal Bloodstream Pathogens
Diagnostics FDA

HSMN NewsFeed - 20 Oct 2009
Novartis drug Tasigna(R) meets primary endpoint in pivotal trial against Gleevec(R) as first-line treatment in chronic myeloid leukemia patients
Biopharmaceuticals Oncology

HSMN NewsFeed - 13 Oct 2009
Nanosphere Announces FDA 510(k) Clearance of the Verigene(R) SP and Respiratory Virus Nucleic Acid Test
Diagnostics FDA

HSMN NewsFeed - 6 Oct 2009
Gen-Probe to Acquire Prodesse, Leader in Molecular Testing for Respiratory Infectious Diseases, for $60 Million in Cash Plus Potential Milestone Payments
Diagnostics Acquisitions

HSMN NewsFeed - 29 Sep 2009
Hologic Receives CE Marking for the ThinPrep(R) Integrated Imager
Diagnostics Regulatory

Return to NewsFeed

Additional items found! 155

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 155 additional stories matching:
molecular diagnostic
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.